Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20-positive Hematological Malignancies”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Early research (Phase 1)Study completedNCT00788684
What this trial is testing

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

Who this might be right for
CD20-Positive Lymphoid MalignanciesChronic Lymphoid LeukemiaHematological Malignancies+1 more
AbbVie 29
Early research (Phase 1)UnknownNCT05489276
What this trial is testing

Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors

Who this might be right for
Hematological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 180
Early research (Phase 1)Not Yet RecruitingNCT07110194
What this trial is testing

Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies

Who this might be right for
CD20-positive Hematological Malignancies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 75
Early research (Phase 1)Study completedNCT02924402
What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for
B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Xencor, Inc. 154
Testing effectiveness (Phase 2)Study completedNCT00439556
What this trial is testing

Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant

Who this might be right for
CD20 PositiveHematopoietic and Lymphoid Cell NeoplasmLymphocytic Neoplasm+1 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT05348889
What this trial is testing

First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies

Who this might be right for
Non-Hodgkin's Lymphoma (disorder)Acute Lymphoid Leukemia, Disease (disorder)
Chimagen Biosciences, Ltd 7